Correlation Between Iteos Therapeutics and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Iteos Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Revolution Medicines.

Diversification Opportunities for Iteos Therapeutics and Revolution Medicines

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Iteos and Revolution is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Revolution Medicines go up and down completely randomly.

Pair Corralation between Iteos Therapeutics and Revolution Medicines

Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the Revolution Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Iteos Therapeutics is 1.03 times less risky than Revolution Medicines. The stock trades about -0.04 of its potential returns per unit of risk. The Revolution Medicines is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  4,725  in Revolution Medicines on August 25, 2024 and sell it today you would earn a total of  950.00  from holding Revolution Medicines or generate 20.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Iteos Therapeutics  vs.  Revolution Medicines

 Performance 
       Timeline  
Iteos Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iteos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Revolution Medicines 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Iteos Therapeutics and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iteos Therapeutics and Revolution Medicines

The main advantage of trading using opposite Iteos Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Iteos Therapeutics and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing